Dr. Saul Newman, a researcher at the Oxford Institute of Population Ageing and Ig Nobel Prize winner, challenges the Blue Zones myth, exposing inaccuracies in longevity claims. He highlights that a significant number of centenarians in these regions aren't genuine, revealing corruption behind the sale of Blue Zone certificates for $40 million. Saul discusses the dangers of basing health advice on flawed data and the truth about longevity, emphasizing the critical role of genetics and advocating for a more skeptical approach to aging research.